724 organization(s) found
Belgian Hematology Society
We’re a scientific society composed of more than 500 members: internists, biologists, nurses, other scientists, and patient organisations with a specific interest in the field of hematology.
BeONE Medicines
We’re building the world’s leading oncology company – driven by scientific excellence and exceptional speed – to reach more patients than ever before. Together, we are how the world stops cancer.
Bicycle Therapeutics
Our aim is to become one of the world's leading solid tumor medicines companies, initially measured by our pipeline's potential, and ultimately by the number of patients we are able to treat. Beyond oncology, we recognize the unique potential of our technology and one of our goals is to develop innovative new therapeutics that exploit our unique precision-guided technology through bespoke and creative collaborative relationships.
BioNTech
We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies and mRNA vaccines. We believe in scientific rigor, innovation and passion as a driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence.
Blood Cancer United
Blood Cancer United is the leading organization for everyone affected by blood cancer. And we have been since 1949.
Blood Cancer United (BCU)
We are Blood Cancer United, and we believe everyone with blood cancer deserves a longer, better life. That’s why we are on a mission to cure blood cancer and improve the quality of life of all patients and their families. How? We fund life-saving blood cancer research around the world, provide free information and support services for patients and their families, and are the voice for those seeking access to quality, affordable, coordinated care. With your help, we have invested more than $2 billion in groundbreaking research supporting many of today's most innovative approaches to treatment—helping those with blood cancer not only survive but also thrive.
Blue Bees Therapeutics
Blue Bees Therapeutics is a biotechnology company founded in 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel L�onetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate unique bi-specific receptor/ co-receptor engaging immunomodulatory antibodies.
Boehringer-Ingelheim
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. We strive to improve the health of humans and animals - for generations. We work together with integrity and are guided by a shared purpose that defines who we are and what we do.
brainstrust
We believe in a world where people with a brain tumour and their loved ones are involved, resourced, confident and connected. They are living the life they want, to the best of their potential, because they are people first, and patients and carers second. We provide personalised support and build resources that help people with a brain tumour and their loved ones live the life they want after diagnosis. We work with people in the clinical setting to secure the best possible care for people with a brain tumour and we campaign to solve real issues, because we understand what challenges people with a brain tumour face. Meaningful collaboration and co-creation is a key component of our approach as we work to secure the best outcomes for anyone who is living with a brain tumour.
Brain Tumour Research
A powerful campaigning organisation, Brain Tumour Research is the leading voice of the brain tumour community. Unique and much needed, we are the only national charity focused on finding a cure for all types of brain tumours. We are campaigning to increase the national investment in research into brain tumours to £35 million per year, while fundraising to create a network of seven sustainable Brain Tumour Research Centres of Excellence across the UK.
Breast Cancer UK
At Breast Cancer UK, we believe in a future where fewer people have to face breast cancer as we know that at least 30% of breast cancers are preventable through lifestyle and environmental factors. We exist to make that potential a reality: by empowering people with knowledge, driving evidence-based research, and campaigning for systemic change. We guide people on practical steps to reduce their risk of breast cancer, from diet and weight management to avoiding harmful chemicals and advocating for healthier environments. A distinctive area of our work is shining a spotlight on Endocrine Disrupting Chemicals (EDCs) — substances in everyday products that may interfere with hormones and increase cancer risk. We collaborate with like-minded organisations to amplify our voice on this critical issue, and we fund research we believe has the potential to be a “game-changer.”
Brenus Pharma
At Brenus, we believe innovation is a collective journey. Our team brings together passionate, curious, and complementary talents to push the boundaries of science and improve patient’s lives. Through our off-the-shelf platform, we are advancing next-generation in vivo immunotherapies to unlock immune responses against solid tumors.
Brigham and Women’s Faulkner Hospital
Brigham and Women's Faulkner Hospital (BWFH) is a 171 bed non-profit, community teaching hospital located in Jamaica Plain, just 3.4 miles from the Longwood medical area, and across the street from the Arnold Arboretum. Founded in 1900, BWFH has a long history of meeting the health care needs of the residents of southwest Boston and surrounding suburbs (read more about our history here). At Brigham and Women's Faulkner Hospital, we believe that everyone should have the chance to live a healthy life. That's why we're connected to people wherever they are – in the neighborhoods where they live and play, in the places where they work, and increasingly where we can reach more people than ever before – online. From creating breakthroughs that have paved the way for treatments around the globe to training the next generation of providers, our patients, and those we may never meet, are at the center of everything we do. We are committed to increasing access to high-quality, personalized care for the patients and communities we serve and addressing obstacles that prevent achieving excellent health outcomes. Brigham and Women's Faulkner Hospital is at its best when every employee feels equal, included, empowered and respected. When our employees feel supported our patients benefit from their transparency, creativity and innovation because we're all in this together. And together, we all thrive.
Bright Peak Therapeutics
Bright Peak Therapeutics is a biotechnology company advancing “next-generation” multi-functional PD-1 inhibitors, integrating both novel and validated mechanisms.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
British Skin Foundation
The British Skin Foundation is the only UK charity that raises money to fund research into all types of skin diseases, including skin cancer.
British Society of Haematology (BSH)
The British Society for Haematology (BSH) has been bringing haematology professionals together since 1960 to transform the care our members provide to patients. With over 3,000 members worldwide, we are the largest UK haematology organisation and the only society to cover all aspects of the speciality. Listening: Our members work together to share ideas and knowledge and to champion and strengthen haematology practice Learning: Together we help shape the future of haematology by providing access to resources, events and education that support your professional development Leading: Bridging the gap between research and practice, our guidelines raise the standards of clinical and patient care
Byondis
"Byondis's ambition is to become a leading pharmaceutical company by discovering, developing and delivering proprietary breakthrough medicinal modalities to patients in the field of cancer and other difficult to treat diseases." - Jacques Lemmens, PhD, Founder / Chairman of the Board
CAB (Cancer Association of Botswana)
Volunteer-run NGO established in 1998 to reduce the impact of cancer by promoting early detection, awareness, counseling, and support including temporary accommodation for patients during treatment.